Anticancer drug development guide: preclinical screening, clinical trials, and approval
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Totowa, NJ
Humana Press
1997
|
| Schriftenreihe: | Cancer drug discovery and development
2 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XII, 311 S. graph. Darst. |
| ISBN: | 0896034615 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011340450 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 970514s1997 d||| |||| 00||| eng d | ||
| 020 | |a 0896034615 |9 0-89603-461-5 | ||
| 035 | |a (OCoLC)36084033 | ||
| 035 | |a (DE-599)BVBBV011340450 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 050 | 0 | |a RC271.C5 | |
| 082 | 0 | |a 616.99/4061 |2 21 | |
| 084 | |a XI 7000 |0 (DE-625)153024:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Anticancer drug development guide |b preclinical screening, clinical trials, and approval |c ed. by Beverly A. Teicher |
| 264 | 1 | |a Totowa, NJ |b Humana Press |c 1997 | |
| 300 | |a XII, 311 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Cancer drug discovery and development |v 2 | |
| 650 | 4 | |a Antineoplastic Agents |x standards | |
| 650 | 4 | |a Antineoplastic agents |x Development | |
| 650 | 4 | |a Drug Approval | |
| 650 | 4 | |a Drug Evaluation, Preclinical | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Teicher, Beverly A. |e Sonstige |4 oth | |
| 830 | 0 | |a Cancer drug discovery and development |v 2 |w (DE-604)BV011340435 |9 2 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007619690&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007619690 | ||
Datensatz im Suchindex
| _version_ | 1804125849102843904 |
|---|---|
| adam_text | ANTICANCER DRUG DEVELOPMENT GUIDE PRECLINICAL SCREENING, CLINICAL
TRIALS, AND APPROVAL EDITED BY BEVERLY A. TEICHER DANA-FARBER CANCER
INSTITUTE, BOSTON, MA HUMANA PRESS TOTOWA, NEW JERSEY CONTENTS SERIES
PREFACE V PREFACE V/7 CONTRIBUTORS XI PART I. IN VITRO METHODS 1
HIGH-VOLUME SCREENING 3 MICHEL PAGE 2 THE NCI IN VITRO ANTICANCER DRUG
DISCOVERY SCREEN: CONCEPT, IMPLEMENTATION, AND OPERATION, 1985*1995 23
MICHAEL R. BOYD 3 HUMAN TUMOR SCREENING 43 AXEL-R. HANAUSKE, SUSAN G.
HILSENBECK, AND DANIEL D. VON HOJF PART II. IN VIVO METHODS 4 MURINE
L1210 AND P388 LEUKEMIAS 59 WILLIAM R. WAUD 5 IN VIVO METHODS FOR
SCREENING AND PRECLINICAL TESTING: USE OF RODENT SOLID TUMORS FOR DRUG
DISCOVERY 75 THOMAS CORBETT, FRED VALERIOTE, PATRICIA LORUSSO, LISA
POLIN, CHIAB PANCHAPOR, SUSAN PUGH, KATHRYN WHITE, JUIWANNA KNIGHT, LISA
DEMCHIK, JULIE JONES, LYNNE JONES, AND LORETTA LISOW 6 HUMAN TUMOR
XENOGRAFT MODELS IN NCI DRUG DEVELOPMENT ... 101 JAQUELINE PLOWMAN,
DONALD J. DYKES, MELINDA HOLLINGSHEAD, LINDA SIMPSON-HERREN, AND MICHAEL
C. ALLEY 7 FERTILE SEED AND RICH SOIL: THE DEVELOPMENT OF CLINICALLY
RELEVANT MODELS OF HUMAN CANCER BY SURGICAL ORTHOTOPIC IMPLANTATION OF
INTACT TISSUE 127 ROBERT M. HOFFMAN 8 PRECLINICAL MODELS FOR HIGH-DOSE
THERAPY 145 BEVERLY A. TEICHER 9 MODELS FOR MINIMAL RESIDUAL TUMOR 183
BEVERLY A. TEICHER 10 SPONTANEOUSLY OCCURRING TUMORS IN COMPANION
ANIMALS AS MODELS FOR DRUG DEVELOPMENT 197 DAVID M. VAIL AND E. GREGORY
MACEWEN PART III. CLINICAL TESTING 11 WORKING WITH THE NATIONAL CANCER
INSTITUTE 217 EDWARD A. SAUSVILLE IX CONTENTS 12 PHASE I TRIAL DESIGN
AND METHODOLOGY 227 DEBORAH L. TOPPMEYER 13 PHASE II CLINICAL TRIALS IN
ONCOLOGY 249 CHRISTINE KHATER, PAUL LAUB, JAMES M. GALLO, ANDRE ROGATKO,
AND PETER J. O DWYER 14 DRUG DEVELOPMENT IN EUROPE 271 THOMAS ANTHONY
CONNORS AND HERBERT M. PINEDO 15 THE PHASE III CANCER CLINICAL TRIAL 289
EMILFREILLL 16 FDA ROLE IN CANCER DRUG DEVELOPMENT AND REQUIREMENTS FOR
APPROVAL 293 ROBERT L. JUSTICE INDEX 305
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV011340450 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.C5 |
| callnumber-search | RC271.C5 |
| callnumber-sort | RC 3271 C5 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 7000 |
| ctrlnum | (OCoLC)36084033 (DE-599)BVBBV011340450 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01776nam a2200445 cb4500</leader><controlfield tag="001">BV011340450</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970514s1997 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0896034615</subfield><subfield code="9">0-89603-461-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)36084033</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011340450</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7000</subfield><subfield code="0">(DE-625)153024:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anticancer drug development guide</subfield><subfield code="b">preclinical screening, clinical trials, and approval</subfield><subfield code="c">ed. by Beverly A. Teicher</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 311 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer drug discovery and development</subfield><subfield code="v">2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teicher, Beverly A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer drug discovery and development</subfield><subfield code="v">2</subfield><subfield code="w">(DE-604)BV011340435</subfield><subfield code="9">2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007619690&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007619690</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV011340450 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:08:05Z |
| institution | BVB |
| isbn | 0896034615 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007619690 |
| oclc_num | 36084033 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XII, 311 S. graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Humana Press |
| record_format | marc |
| series | Cancer drug discovery and development |
| series2 | Cancer drug discovery and development |
| spelling | Anticancer drug development guide preclinical screening, clinical trials, and approval ed. by Beverly A. Teicher Totowa, NJ Humana Press 1997 XII, 311 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer drug discovery and development 2 Antineoplastic Agents standards Antineoplastic agents Development Drug Approval Drug Evaluation, Preclinical Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Cytostatikum (DE-588)4068347-3 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Teicher, Beverly A. Sonstige oth Cancer drug discovery and development 2 (DE-604)BV011340435 2 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007619690&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Anticancer drug development guide preclinical screening, clinical trials, and approval Cancer drug discovery and development Antineoplastic Agents standards Antineoplastic agents Development Drug Approval Drug Evaluation, Preclinical Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4068347-3 (DE-588)4143413-4 |
| title | Anticancer drug development guide preclinical screening, clinical trials, and approval |
| title_auth | Anticancer drug development guide preclinical screening, clinical trials, and approval |
| title_exact_search | Anticancer drug development guide preclinical screening, clinical trials, and approval |
| title_full | Anticancer drug development guide preclinical screening, clinical trials, and approval ed. by Beverly A. Teicher |
| title_fullStr | Anticancer drug development guide preclinical screening, clinical trials, and approval ed. by Beverly A. Teicher |
| title_full_unstemmed | Anticancer drug development guide preclinical screening, clinical trials, and approval ed. by Beverly A. Teicher |
| title_short | Anticancer drug development guide |
| title_sort | anticancer drug development guide preclinical screening clinical trials and approval |
| title_sub | preclinical screening, clinical trials, and approval |
| topic | Antineoplastic Agents standards Antineoplastic agents Development Drug Approval Drug Evaluation, Preclinical Arzneimittelentwicklung (DE-588)4143176-5 gnd Cytostatikum (DE-588)4068347-3 gnd |
| topic_facet | Antineoplastic Agents standards Antineoplastic agents Development Drug Approval Drug Evaluation, Preclinical Arzneimittelentwicklung Cytostatikum Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007619690&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV011340435 |
| work_keys_str_mv | AT teicherbeverlya anticancerdrugdevelopmentguidepreclinicalscreeningclinicaltrialsandapproval |